The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Kailash Shantilal Choudhari
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Kailash Shantilal Choudhari, a promoter and director of Aksh Optifibre Ltd, has transferred 30,00,000 equity shares (1.84% of total share capital) to Mrs. Mona Kailash Choudhari by way of an off-market gift on May 30, 2025. This is an inter-se transfer within the promoter family, as both parties are listed as Persons Acting in Concert (PAC). Post-transfer, Dr. Choudhari's holding reduces from 5.56% (90,52,868 shares) to 3.72% (60,52,868 shares), while Mrs. Choudhari's holding rises to 1.84% (30,00,000 shares). The total promoter group (PAC) holding remains unchanged at 9.41% (1,53,25,583 shares) since the shares simply moved within the same family group. No consideration was paid — this was a gift transfer.
This is a family reshuffle within the promoter group with no change in overall promoter ownership (remains 9.41%), so it is unlikely to have any material impact on the stock price or minority shareholders. Investors should note the lower individual concentration in Dr. Choudhari's name, but the consolidated promoter control is unchanged.